Trial RPCEC00000346
Publication Hernandez-Bernal, EClinicalMedicine, 2022
Primary outcome on the report: Safety of the candidate (the non-occurrence of serious adverse events with a causal relationship attributable to the research product in no more than 5% of the subjects)

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.